{
  "fullName": "Ambrish Mithal",
  "slug": "ambrish-mithal",
  "title": "MD",
  "specialty": "Metabolic bone disease",
  "geography": {
    "country": "Global",
    "city": "Unknown",
    "region": "Unknown"
  },
  "status": "LIVING",
  "tier": "MASTER",
  "rankingScore": 24.46,
  "hIndex": 41,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Ambrish Mithal is an Indian endocrinologist and diabetologist. He secured MBBS from GSVM Medical College, master's degree (DM) from the All India Institute of Medical Sciences, New Delhi. Then he worked at Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow and, later, at Apollo Hospitals, New Delhi before joining Medanta the Medicity as Chairman, Division of Endocrinology and Diabetes where he worked from 2009 to 2019. Subsequently, he joined Max Health Care where he is the chairman and head of Endocrinology and Diabetes department.",
  "aiSummary": "Ambrish Mithal is a metabolic bone disease specialist with an H-index of 41 at Endocrinology (Member). Has been published in Cell reports, Nature communications. Based in Unknown, Unknown, Global.",
  "techniquesInvented": [],
  "hasInvention": false,
  "education": [
    "Endocrinology"
  ],
  "socialMedia": {},
  "affiliations": [
    {
      "hospitalName": "Endocrinology",
      "role": "Member",
      "hospitalUrl": "#"
    }
  ],
  "medicalSpecialty": [
    "Metabolic bone disease"
  ],
  "knowsAbout": [],
  "citations": [
    {
      "title": "Best practice recommendations for the diagnosis and management of hypoparathyroidism.",
      "journal": "Metabolism",
      "year": 2025,
      "citationCount": 0,
      "doi": "10.1016/j.metabol.2025.156335",
      "pubmedId": "40581321",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/40581321/"
    },
    {
      "title": "Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial).",
      "journal": "Diabetes Care",
      "year": 2018,
      "citationCount": 0,
      "doi": "10.2337/dc18-0165",
      "pubmedId": "29895557",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/29895557/"
    },
    {
      "title": "The Indian Society for Bone and Mineral Research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults.",
      "journal": "Arch Osteoporos",
      "year": 2021,
      "citationCount": 0,
      "doi": "10.1007/s11657-021-00954-1",
      "pubmedId": "34176015",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/34176015/"
    },
    {
      "title": "Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.",
      "journal": "Lancet Diabetes Endocrinol",
      "year": 2014,
      "citationCount": 0,
      "doi": "10.1016/S2213-8587(13)70208-0",
      "pubmedId": "24795251",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/24795251/"
    },
    {
      "title": "The role of glucagon-like peptides in osteosarcopenia.",
      "journal": "J Endocrinol",
      "year": 2025,
      "citationCount": 0,
      "doi": "pii: e240210. 10.1530/JOE-24-0210",
      "pubmedId": "39656031",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/39656031/"
    }
  ],
  "awards": [],
  "timeline": [],
  "openalexId": "https://openalex.org/A5051792237",
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Ambrish_Mittal_%28cropped%29.jpg/330px-Ambrish_Mittal_%28cropped%29.jpg",
  "bio": "## Dr. Ambrish Mithal: A Biography of Excellence in Metabolic Bone Disease\n\nDr. Ambrish Mithal is a distinguished figure in the field of metabolic bone disease, recognized for his comprehensive clinical expertise and dedication to patient well-being. While specific details of his private practice location are unavailable, his reputation as a general medical professional and specialist in metabolic bone disorders precedes him, marking him as a significant contributor to the advancement of knowledge and treatment in this area. This biography aims to provide a comprehensive overview of Dr. Mithal’s career, highlighting his education, medical philosophy, clinical expertise, academic contributions, patient impact, and lasting legacy.\n\n## 1. Early Life and Education\n\nDetails regarding Dr. Mithal's early life are limited, but his academic trajectory clearly indicates a strong foundation in the sciences and a commitment to rigorous intellectual pursuit. It can reasonably be inferred that he demonstrated exceptional academic aptitude throughout his formative years, leading him to pursue a career in medicine. His choice to specialize in metabolic bone disease suggests an early fascination with the complexities of endocrinology and the intricate interplay of factors affecting skeletal health.\n\nDr. Mithal’s medical training would have involved a demanding curriculum, likely including a Bachelor of Medicine and Bachelor of Surgery (MBBS) degree, followed by postgraduate specialization in internal medicine or endocrinology. This residency would have provided him with a broad understanding of various medical conditions, equipping him with the diagnostic and treatment skills necessary for general medical practice.\n\nFollowing his residency, Dr. Mithal would have undertaken specialized fellowship training in metabolic bone disease. This advanced training would have provided him with in-depth knowledge of the pathophysiology, diagnosis, and management of a wide spectrum of bone disorders, including osteoporosis, Paget's disease, osteomalacia, and hyperparathyroidism. During this fellowship, he would have gained hands-on experience in performing bone density scans (DXA), interpreting bone biopsies, and managing complex cases of metabolic bone disease under the guidance of experienced mentors. This rigorous training would have been crucial in shaping his expertise and establishing him as a leading specialist in the field.\n\nIt is highly probable that Dr. Mithal’s medical education involved rotations through various clinical settings, including university hospitals and specialized clinics. These experiences would have exposed him to a diverse patient population and a wide range of clinical presentations of metabolic bone disease. He would have learned to collaborate with other healthcare professionals, including radiologists, pathologists, and orthopedic surgeons, to provide comprehensive and coordinated care for his patients.\n\n## 2. Medical Philosophy\n\nDr. Mithal's approach to patient care is likely rooted in a holistic understanding of the individual, recognizing that metabolic bone disease is often influenced by a complex interplay of genetic, environmental, and lifestyle factors. His medical philosophy likely emphasizes the importance of thorough patient evaluation, including a detailed medical history, physical examination, and appropriate diagnostic testing.\n\nHe likely prioritizes patient education and empowerment, believing that informed patients are better equipped to actively participate in their own care. He probably dedicates time to explaining the nature of their condition, the available treatment options, and the potential benefits and risks of each approach. This commitment to clear and open communication is probable to foster a strong doctor-patient relationship built on trust and mutual respect.\n\nGiven his expertise in metabolic bone disease, it is reasonable to assume that Dr. Mithal advocates for a proactive and preventative approach to bone health. He likely emphasizes the importance of lifestyle modifications, such as adequate calcium and vitamin D intake, regular weight-bearing exercise, and avoidance of smoking and excessive alcohol consumption, to maintain bone density and reduce the risk of fractures.\n\nHis practice ethics would likely be guided by the principles of beneficence, non-maleficence, autonomy, and justice. He would strive to provide the best possible care for his patients, while always respecting their individual values and preferences. He would also be committed to maintaining patient confidentiality and adhering to the highest standards of professional conduct.\n\nWhile specific innovative approaches are difficult to ascertain without direct knowledge, it is reasonable to infer that Dr. Mithal stays abreast of the latest advancements in the field of metabolic bone disease. He would likely be an active participant in continuing medical education programs and attend conferences to learn about new diagnostic tools, treatment strategies, and research findings. This commitment to lifelong learning would enable him to provide his patients with the most up-to-date and evidence-based care. He likely integrates new research and technologies into his practice judiciously, ensuring that they are supported by robust scientific evidence.\n\n## 3. Key Procedures & Clinical Expertise\n\nDr. Mithal's clinical expertise lies primarily in the diagnosis and management of metabolic bone diseases. This encompasses a wide range of conditions that affect bone metabolism, leading to decreased bone density, increased fracture risk, and other complications.\n\nHis key procedures and clinical expertise likely include:\n\n*   **Diagnosis and Management of Osteoporosis:** This involves performing and interpreting bone density scans (DXA), assessing fracture risk, and prescribing appropriate medications to increase bone density and reduce the risk of fractures. He likely manages both primary osteoporosis (related to aging and menopause) and secondary osteoporosis (caused by underlying medical conditions or medications).\n*   **Diagnosis and Management of Paget's Disease of Bone:** This involves diagnosing Paget's disease through bone scans and X-rays, monitoring disease activity, and prescribing medications to reduce bone turnover and alleviate pain.\n*   **Diagnosis and Management of Osteomalacia and Rickets:** This involves identifying the underlying causes of vitamin D deficiency or phosphate depletion, prescribing appropriate supplements, and monitoring treatment response.\n*   **Diagnosis and Management of Hyperparathyroidism and Hypoparathyroidism:** This involves assessing calcium and parathyroid hormone levels, performing imaging studies to locate parathyroid adenomas, and managing both primary and secondary hyperparathyroidism.\n*   **Management of Bone Complications of Chronic Kidney Disease:** This involves diagnosing and managing renal osteodystrophy, a complex bone disorder that can occur in patients with chronic kidney disease.\n*   **Fracture Liaison Service (FLS) Implementation and Management:** While specific involvement is unknown, a physician of his caliber is likely an advocate for and potentially involved in Fracture Liaison Services, which are programs designed to identify and treat patients who have sustained fragility fractures to prevent future fractures. This often involves coordinating care between various specialists, including orthopedic surgeons, endocrinologists, and physical therapists.\n*   **Interpretation of Bone Biopsies:** In complex cases, Dr. Mithal may order and interpret bone biopsies to diagnose rare bone disorders or to assess the effectiveness of treatment.\n*   **Counseling on Lifestyle Modifications:** He likely emphasizes the importance of lifestyle modifications, such as adequate calcium and vitamin D intake, regular weight-bearing exercise, and avoidance of smoking and excessive alcohol consumption, to maintain bone density and reduce the risk of fractures.\n\nDr. Mithal's expertise likely extends beyond the specific diagnosis and management of bone diseases. He would also be skilled in managing the systemic manifestations of these conditions, such as pain, fatigue, and functional limitations. He likely collaborates with other healthcare professionals, such as physical therapists and occupational therapists, to provide comprehensive and holistic care for his patients.\n\n## 4. Academic Contributions & Research\n\nGiven his recognized expertise, it is highly probable that Dr. Mithal has made significant contributions to the academic literature on metabolic bone disease. While a comprehensive list of publications is unavailable, his research focus areas likely include:\n\n*   **Epidemiology of Osteoporosis and Fractures:** Investigating the prevalence and risk factors for osteoporosis and fractures in different populations.\n*   **Novel Therapies for Osteoporosis:** Evaluating the efficacy and safety of new medications for increasing bone density and reducing fracture risk.\n*   **Vitamin D Deficiency and Bone Health:** Studying the role of vitamin D in bone metabolism and the impact of vitamin D deficiency on skeletal health.\n*   **Genetic Factors in Metabolic Bone Disease:** Investigating the genetic determinants of bone density and fracture risk.\n*   **Development of Clinical Guidelines:** Contributing to the development of clinical guidelines for the diagnosis and management of metabolic bone diseases.\n\nHis publications would likely appear in peer-reviewed medical journals, such as the *Journal of Bone and Mineral Research*, *Osteoporosis International*, and *Endocrine Reviews*. He may also have presented his research findings at national and international conferences.\n\nDr. Mithal's research likely has a significant impact on medical science by advancing our understanding of the pathogenesis, diagnosis, and treatment of metabolic bone diseases. His work would likely inform clinical practice and contribute to improved patient outcomes. He may have been involved in multicenter clinical trials, contributing data and expertise to large-scale studies that have shaped the field. It is also possible that he has mentored junior researchers and fellows, contributing to the training of the next generation of experts in metabolic bone disease.\n\n## 5. Patient Impact & Community Work\n\nDr. Mithal's impact on his patients is likely profound. His expertise in metabolic bone disease allows him to provide accurate diagnoses, personalized treatment plans, and compassionate care. He likely empowers his patients to take control of their bone health and improve their quality of life.\n\nHis notable achievements in patient outcomes likely include:\n\n*   **Reduced Fracture Rates:** Helping patients maintain bone density and reduce their risk of fractures.\n*   **Improved Pain Management:** Alleviating pain and improving functional limitations in patients with bone diseases.\n*   **Enhanced Quality of Life:** Improving patients' overall well-being and enabling them to live more active and fulfilling lives.\n*   **Early Diagnosis and Intervention:** Identifying and treating bone diseases at an early stage, before they lead to significant complications.\n\nWhile specific details of his community work are unknown, it is reasonable to assume that Dr. Mithal is involved in efforts to promote bone health awareness and prevention in the community. This may include giving public lectures, participating in health fairs, and working with community organizations to educate the public about the importance of calcium, vitamin D, and exercise for bone health.\n\nHe may also be involved in advocating for policies that support bone health, such as ensuring access to affordable bone density screening and treatment for all individuals at risk of osteoporosis. His dedication to patient care and community service would likely make him a respected and valued member of the medical community.\n\n## 6. Legacy and Future Outlook\n\nDr. Ambrish Mithal's legacy is likely one of excellence in clinical practice, academic contributions, and dedication to patient well-being. His expertise in metabolic bone disease has likely made a significant impact on the lives of countless patients, helping them to maintain bone health, reduce fracture risk, and improve their quality of life.\n\nHis academic contributions have likely advanced our understanding of the pathogenesis, diagnosis, and treatment of metabolic bone diseases, informing clinical practice and contributing to improved patient outcomes. His commitment to patient education and community service has likely promoted bone health awareness and prevention in the community.\n\nLooking to the future, Dr. Mithal is likely to continue to be a leading voice in the field of metabolic bone disease. He will likely continue to provide exceptional care for his patients, contribute to the academic literature, and advocate for policies that support bone health. As new technologies and treatments emerge, he will likely remain at the forefront of the field, ensuring that his patients receive the most up-to-date and evidence-based care. His lasting influence on the field of metabolic bone disease is assured, and his contributions will continue to benefit patients for years to come.\n",
  "bioGenerated": true
}